Skip to main content

What the FDA labels say about taking them together

Thioridazine and zaleplon

Zaleplon's FDA label of May 8, 2024 names thioridazine in its drug interactions section; the thioridazine label PlainMeds reads does not name zaleplon. The zaleplon label: “Thioridazine Coadministration of single doses of zaleplon 20 mg and thioridazine 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.”

Check it at the source: the thioridazine FDA label on DailyMed (effective November 11, 2025, Mylan Institutional Inc.); the zaleplon FDA label on DailyMed (effective May 8, 2024, Aurobindo Pharma Limited).

What does the thioridazine label say about zaleplon?

Thioridazine's label (effective November 11, 2025) does not name zaleplon in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Thioridazine Hydrochloride), Mylan Institutional Inc., effective November 11, 2025 (SPL set 52fea941-0b47-41c1-b00d-f88150e8ab93), via openFDA; the full label on DailyMed

What does the zaleplon label say about thioridazine?

Zaleplon label, drug interactions

Thioridazine Coadministration of single doses of zaleplon 20 mg and thioridazine 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.

Source: FDA drug label (ZALEPLON), Aurobindo Pharma Limited, effective May 8, 2024 (SPL set e092f3ca-bf44-4568-a72c-3fb2cf5b192b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Thioridazine generic labelers
9Zaleplon generic labelers
ThioridazineZaleplon
Labeled forn/aInsomnia
Boxed warningYesYes
Pharmacy cost (NADAC)$0.571 per tablet 25 mg tablet$0.141 per capsule 10 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?